Bayer’s controversial permanent nonsurgical contraceptive device Essure will no longer be sold or distributed in the United States after the first of the year in response to thousands of complaints, but the Food and Drug Administration (FDA) will continue its oversight of the device still implanted in thousands of women. Its manufacturer also is required to continue to study Essure side effects for the next five years and provide reports to the FDA. “When new safety concerns arise for particular devices, we’re committed to taking action to develop post-market information that can help patients and providers make more informed decisions ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.